Altmetrics
Downloads
102
Views
54
Comments
0
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Submitted:
23 August 2024
Posted:
26 August 2024
You are already at the latest version
Total sugar mg GE/100 g FM | |||
---|---|---|---|
TG | TM | AW | |
M1 | 1720±76.22dA | 1709±72.63cA | 1889 ± 124.8bA |
M2 | 1814±84.36cdA | 1721±91.97bcA | 1636 ± 36.63cA |
M3 | 1880±7.31bcB | 1987±71.89aA | 1982 ±55.23abA |
M4 | 2032±22.35bA | 1880±25.34abA | 1940±27.93abA |
M5 | 2134±56.23aA | 1904 ± 20.8aA | 2098 ±34.57aA |
TPC mg GAE/100g FM | TFC mg QE/100g FM | TCT mg CE/100g FM | |||||||
TG | TN | AW | TG | TN | AW | TG | TN | AW | |
M1 | 2813 ± 58.02bA |
3014 ± 59.13bA |
2734 ± 99.24aA |
826.2 ± 40.77bB |
298.7 ± 20.1cC |
1423 ± 78.47aA |
613.9 ± 74.18bA |
231.2 ± 69.86cB |
567.9 ± 21.35bA |
M2 | 3475 ± 189.6aB |
3819 ± 226.4aA |
2765 ± 144.3aC |
925.4 ± 13.27aAB |
1034 ± 57.08aA |
830.1 ± 87.62bB |
848.1 ± 18.91aB |
1472 ± 28.46aA |
756.1 ± 92.54 aC |
M3 | 2750 ± 98.37bcA |
2368 ± 43.12cB |
2209 ± 86.94bC |
900.6 ± 65.7abA |
827.5 ± 49.6bA |
848.4 ± 52.7bA |
628.5 ± 93.07bA |
633.7 ± 61.17bA |
539.6 ± 35.26bB |
M4 | 2532 ± 48.3cA |
2120 ± 150.9cB |
1947 ± 55.37cB |
173.2 ± 11.25dA |
196.2 ± 10.96dA |
161.2 ± 13.73cA |
724.7 ± 22.69abA |
706.9 ± 37.82bAB |
565.8 ± 18.38bB |
M5 | 2744 ± 39.47bcA |
2391 ± 76.58cC |
2595 ± 91.21aB |
294 ± 12.06cA |
249.6 ± 16.76cdA |
305.6 ± 11.95cA |
75.71 ± 5.52cA |
71.42 ± 3.32dA |
77.17 ± 6.11cA |
N° | Compounds | Chemical formula | RT (min) | %AIR | Ref | ||
---|---|---|---|---|---|---|---|
TM | AW | TG | |||||
1 | 3-O-p-coumaroyl 5-O-caffeoylquinic acid | C25H24O11 | 4.28 | 53.40 | 63.62 | 55.84 | N |
2 | Quercetin 3-methyl ether | C16H12O7 | 5.26 | 13.87 | 12.91 | 13.83 | N |
3 | Gallic acid | C7H6O5 | 6.60 | 11.24 | 5.17 | 2.35 | S |
4 | 3,4-Dicaffeoylquinic acid | C25H24O12 | 8.43 | 3.04 | 2.85 | 5.06 | N |
5 | Galloylquinic acid | C14H16O10 | 10.95 | 12.55 | n.d | n.d | (1) |
6 | Ferulic acid | C10H10O4 | 13.52 | 0.34 | 0.37 | 0.60 | S |
7 | Catechine | C15H14O6 | 17.84 | n.d | 0.37 | n.d | S |
Doses Symptoms |
2 g/kg | 1 g/kg | 0.5 g/kg |
---|---|---|---|
Locomotion and mobility | Normal | Normal | Normal |
Hair loss or erection | - | - | - |
Diarrhea | - | - | - |
Abnormal agitation | - | - | - |
Anorexia | - | - | - |
Spontaneous startle | - | - | - |
Isolation in the corner | - | - | - |
Mortality | - | - | - |
Body weight gain | Normal | Normal | Normal |
Extraits | IC50 µg/mL |
---|---|
TG | 0,591 ± 0.104a |
TM | 0,450 ± 0.239 ab |
AW | 0,405 ± 0.247 ab |
Acarbose (control) | 0,098 ± 0.004 b |
Extraits | IC50 µg/mL |
TG | 0,063 ± 0.002 b |
TM | 0,086 ± 0.014 a |
AW | 0,065 ± 0.004 b |
Acarbose (control) | 0,089 ± 0.004 a |
α-amylase (PDB:1B2Y) |
α-glucosidase (PDB: 5NN8) |
|||
Compound name |
Affinity (Kcal/mol) |
Interaction Site |
Affinity (Kcal/mol) |
Interaction Site |
Acarbose (Standard inhibitor) |
-8.2 | Tyr 2, Ser 3, Pro 4, Thr 6, Gln 8, Phe 222, Arg 252, Pro 332, Gly 334, Arg 398. | -7.2 | Asp 356, Val 357, Arg 608, His 584, His 717, Leu 865, Glu 866. |
3-O-p-Coumaroyl-5-O-caffeoylquinic acid | -9.2 | Pro 4, Tyr 6, Arg 252, Trp 280, His 331, Pro 332, Arg 398, Arg 421 | -8.2 | Lys 348, His 708, Arg 725, Ala 749, Ile 823 Glu 856 |
Quercetin 3-methyl ether | -8.2 | Arg 267, Arg 303, Thr 314, Arg 346, Asp 356 | -7.1 | Met 363, Arg 585, Arg 594 |
Gallic acid | -5.9 | Val 129, Gly 181, Tyr 182 | -5.8 | His 708, Gln 715, Glu 748, Ala 749, Ile 823, Glu 856. |
3,4-Dicaffeoylquinic acid | -8.2 | Pro4, Gln 8, Gly 9, Pro 332, Phe 335, Thy 336, Arg 398, Asp 402, Arg 421 | -7.9 | Met 363, Arg 585, Arg 594, Tyr 609, His 717, Glu 866, |
Galloylquinic acid | -7.2 | Arg 10, Arg 252, Ser 289, Gly 334, Asp 402, Gly 403 | -6.4 | Leu 195, Arg 585, Tyr 609 |
Ferulic acid | -6.3 | Arg 552, Ser 289, Pro 332, Phe 335, Arg 424 | -6.6 | His 708, Glu 721, Arg 725, Tyr 822, Gly 855, Glu 856 |
Catechin | -7.8 | Asn 301, Ile 312, Thr 314, Asp 317, Arg 346, Asn 352 | -6.8 | Pro 194, Leu 195, Phe 490, Thr 491, Leu 577, Ile 581, Tyr 609 |
Physicochemical Properties | Lipophilicity | Druglikeness | Pharmacokinetics | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Compounds | MW g/mol | HBA | HBD | TPSA Ų | ROTB | MlogP | WlogP | Lipinski’s | Verber’s | GI absorption | BBB Permea- tion |
CYP1A2 Inhibitor |
3-O-p-Coumaroyl-5-O-caffeoylquinic acid | 500.4 | 11 | 6 | 191.0 | 9 | 0.1 | 1.1 | 3 | 1 | Low | No | No |
Quercetin 3-methyl ether | 316.2 | 7 | 4 | 120.3 | 2 | -0.3 | 2.2 | 0 | 0 | High | No | No |
Gallic acid | 170.1 | 5 | 4 | 97.9 | 1 | -0.1 | 0.5 | 0 | 0 | High | No | No |
3,4-Dicaffeoylquinic acid | 516.4 | 12 | 7 | 211.2 | 9 | -0.3 | 0.8 | 3 | 1 | Low | No | No |
Galloylquinic acid | 344.2 | 10 | 8 | 195.8 | 3 | -2.7 | -2.1 | 1 | 1 | Low | No | No |
Ferulic acid | 194.1 | 4 | 2 | 66.7 | 3 | 1.0 | 1.3 | 0 | 0 | High | Yes | No |
Catechin | 290.2 | 6 | 5 | 110.3 | 1 | 0.2 | 1.2 | 0 | 0 | High | No | No |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated